These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36781630)

  • 1. Content Validity and Cognitive Debriefing of a Patient-Reported Outcome Instrument Evaluating Symptoms and Disease Impact in Patients with Geographic Atrophy.
    Morga A; Chamberlain CX; Meyers O; Roberts C; Gaspar L; Su J
    Ophthalmol Ther; 2023 Apr; 12(2):1181-1193. PubMed ID: 36781630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the patient experience of chronic kidney disease stages 2-3b: a qualitative interview study with Kidney Disease Quality of Life (KDQOL-36) debrief.
    Rydén A; Nolan S; Maher J; Meyers O; Kündig A; Bjursell M
    BMC Nephrol; 2022 Jun; 23(1):201. PubMed ID: 35641914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qualitative exploration of the visual function impairments and impacts on vision-dependent activities of daily living in Retinitis Pigmentosa and Leber Congenital Amaurosis: content validation of the ViSIO-PRO and ViSIO-ObsRO measures.
    Kay C; Audo I; Naujoks C; Spera C; Fischer MD; Green J; Durham T; Williamson N; Bradley H; Barclay M; Sims J; Banhazi J; Patalano F
    J Patient Rep Outcomes; 2023 Jul; 7(1):74. PubMed ID: 37466759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development, psychometric evaluation and cognitive debriefing of the rheumatoid arthritis symptom and impact questionnaire (RASIQ).
    Becker B; Bracher M; Chauhan D; Rendas-Baum R; Lin X; Raymond K; O'Connor M; Kosinski M
    J Patient Rep Outcomes; 2021 Dec; 5(1):129. PubMed ID: 34894330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Novel Patient-Reported Outcome (PRO) and Observer-Reported Outcome (ObsRO) Instruments in Retinitis Pigmentosa (RP) and Leber Congenital Amaurosis (LCA): ViSIO-PRO and ViSIO-ObsRO.
    Audo I; Patalano F; Naujoks C; Spera C; Fischer MD; Green J; Kay C; Durham T; Williamson N; Bradley H; Barclay M; Boparai K; Banhazi J
    Ophthalmol Ther; 2023 Aug; 12(4):2069-2085. PubMed ID: 37210697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Patient Experience: Symptoms and Impact of Dry Age-Related Macular Degeneration.
    Schultz NM; Braunack-Mayer L; Schwartz J; Gaspar L
    Ophthalmol Ther; 2021 Mar; 10(1):151-164. PubMed ID: 33512689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qualitative Research to Understand the Patient Experience and Evaluate Content Validity of the Chronic Ocular Pain Questionnaire (COP-Q).
    Karpecki PM; Findley A; Sloesen BJ; Hodson N; Bentley S; Arbuckle R; O'Brien P; Montecchi-Palmer M; Naujoks C; Hamrah P
    Ophthalmol Ther; 2024 Feb; 13(2):615-633. PubMed ID: 38183618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and exploration of the content validity of a patient-reported outcome measure to evaluate the impact of migraine- the migraine physical function impact diary (MPFID).
    Hareendran A; Mannix S; Skalicky A; Bayliss M; Blumenfeld A; Buse DC; Desai PR; Ortmeier BG; Sapra S
    Health Qual Life Outcomes; 2017 Nov; 15(1):224. PubMed ID: 29149901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the Content Validity of the Unified Wilson Disease Rating Scale: Insights from Qualitative Research.
    Karantzoulis S; Heuer K; Sparling N; Meltzer B; Teynor M
    Adv Ther; 2024 May; 41(5):2070-2082. PubMed ID: 38573483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of the Multiple Myeloma Symptom and Impact Questionnaire: A New Patient-Reported Outcome Instrument to Assess Symptom and Impacts in Patients With Multiple Myeloma.
    Gries KS; Fastenau J; Seo C; Potrata B; Iaconangelo C; Serrano D
    Value Health; 2021 Dec; 24(12):1807-1819. PubMed ID: 34838279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Content Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM) for Assessment of Plaque Psoriasis.
    Gottlieb AB; Ciaravino V; Cioffi C; Peterson L; Warren RB
    Dermatol Ther (Heidelb); 2020 Dec; 10(6):1255-1272. PubMed ID: 32844372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience of Daily Life with Generalized Myasthenia Gravis: A Qualitative Investigation and Assessment of Instrument Content Validity.
    Hartford CA; Sherman SA; Karantzoulis S; Guillemin I; Phinney MG; Kelly KL; Negron KE; Raja SM; Rofail D
    Neurol Ther; 2023 Dec; 12(6):2079-2099. PubMed ID: 37747661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a patient-reported outcome measure for psychotherapeutic interventions in people with seizures: A mixed methods study.
    Michaelis R; Meyer S; Reuber M; Schöne C
    Epilepsy Behav; 2019 Oct; 99():106464. PubMed ID: 31421518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT®) questionnaire: a new patient-reported outcome instrument for PAH.
    McCollister D; Shaffer S; Badesch DB; Filusch A; Hunsche E; Schüler R; Wiklund I; Peacock A;
    Respir Res; 2016 Jun; 17(1):72. PubMed ID: 27301413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global Burden of Dry Age-Related Macular Degeneration: A Targeted Literature Review.
    Schultz NM; Bhardwaj S; Barclay C; Gaspar L; Schwartz J
    Clin Ther; 2021 Oct; 43(10):1792-1818. PubMed ID: 34548176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The development of a patient-reported outcome measure for assessing nighttime symptoms of chronic obstructive pulmonary disease.
    Hareendran A; Palsgrove AC; Mocarski M; Schaefer ML; Setyawan J; Carson R; Make B
    Health Qual Life Outcomes; 2013 Jun; 11():104. PubMed ID: 23799883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and content validation of the Symptoms Evolution of COVID-19: a patient-reported electronic daily diary in clinical and real-world studies.
    Rofail D; McGale N; Im J; Rams A; Przydzial K; Mastey V; Sivapalasingam S; Podolanczuk AJ
    J Patient Rep Outcomes; 2022 May; 6(1):41. PubMed ID: 35507193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a questionnaire to assess the impact of chronic low back pain for use in regulated clinical trials.
    Stokes J; Evans CJ; Pompilus F; Shields AL; Summers KH
    Patient; 2013; 6(4):291-305. PubMed ID: 24062234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a novel PRO instrument for use in familial chylomicronemia syndrome.
    Davidson D; Slota C; Vera-Llonch M; Brown TM; Hsieh A; Fehnel S
    J Patient Rep Outcomes; 2021 Aug; 5(1):72. PubMed ID: 34382114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qualitative Assessment of the Symptoms and Impact of Pancreatic Exocrine Insufficiency (PEI) to Inform the Development of a Patient-Reported Outcome (PRO) Instrument.
    Johnson CD; Arbuckle R; Bonner N; Connett G; Dominguez-Munoz E; Levy P; Staab D; Williamson N; Lerch MM
    Patient; 2017 Oct; 10(5):615-628. PubMed ID: 28332032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.